Linagliptin Impurity 94 |
|
|---|---|
| CAT. No : | L460195 |
| CAS. No : | 2749409-37-6 |
| Mol. F : | C19H24N6O2 |
| Mol. Wt : | 368.43 g/mol |
| Synonyms : | 1H-Purine-2,6-dione,8-[(3R)-3-amino-1-piperidinyl]-1,7-di-2-butyn-1-yl-3,7-dihydro-3-methyl;8-[(3R)-3-Amino-1-piperidinyl]-1,7-di-2-butyn-1-yl-3,7-dihydro-3-methyl-1H-purine-2,6-dione |
| Chemical Name : | (R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione |
| Stock Status : | Instock |
- Buy High-Quality Linagliptin Impurity 94 from Simson Pharma Limited at best competitive price.
- Every compound produced by Simson Pharma is accompanied by Certificate of Analysis.
Product Applications & Regulatory Search Terms:
Buy 2749409-37-6 | Purchase 2749409-37-6 | Order 2749409-37-6 | Enquire 2749409-37-6 | Price of 2749409-37-6 | 2749409-37-6 Supplier | 2749409-37-6 Manufacturer | 2749409-37-6 Exporter | Linagliptin Impurity 94 for Method Validation | Linagliptin Impurity 94 Reference Standard | Linagliptin Impurity 94 for ANDA Filing | Linagliptin Impurity 94 for Forced Degradation Studies | Linagliptin Impurity 94 Identification Standards | Linagliptin Impurity 94 for DMF Filing | Buy high quality Linagliptin Impurity 94 | Purchase Linagliptin Impurity 94 | Linagliptin Impurity 94 suppliers | Linagliptin Impurity 94 manufacturers | Linagliptin Impurity 94 price | Linagliptin Impurity 94 exporter | Order Linagliptin Impurity 94 | Enquire Linagliptin Impurity 94 | Linagliptin Impurity 94 cost | Linagliptin Impurity 94 Supplier | Linagliptin Impurity 94 Distributor
Disclaimer:
The information provided on this webpage is based on the best available knowledge at the time of creation. However, accuracy and completeness are not guaranteed. Product specifications may change without notice, and it is the responsibility of the purchaser, user, or importer of record to verify the accuracy and suitability of the product at the time of ordering.
This product is intended for research use only and is not approved for human consumption.
